Celgene Corporation (CELG)

Price$90.69 (February 15th, 2019)
Change+0.01%
Sector: Healthcare
Industry:Biotechnology
Website:http://www.celgene.com
Description:Celgene Corp is a biotech company that discovers, develops, and commercializes therapies designed to treat cancer and immune-inflammatory related diseases. Its registered brands are Abraxane, Istodax, Otezla, Pomalyst, Revlimid, Thalomid, Vidaza.
Current Rating: 72

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice.